Posthemorrhagic hydrocephalus treatment may help infants avoid brain shunt
A temporary treatment for posthemorrhagic hydrocephalus in newborns may lower the chance that a baby will later need a brain shunt.
A temporary treatment for posthemorrhagic hydrocephalus in newborns may lower the chance that a baby will later need a brain shunt.
New research suggests FcRn inhibitors may one day help prevent platelet destruction in conditions like immune thrombocytopenia and FNAIT.
Researchers found that while IVIG can be lifesaving in FNAIT, much of its obstetrical use occurs outside federally licensed indications.
A two-day simulation-based course improved nurses’ readiness to treat obstetric crises linked to FNAIT and other complications.
The HLA/HPA Platelet Program at Canadian Blood Services, which serves patients with FNAIT, has seen an increased need for matched platelets.
A pregnant patient with a history of fetal death was diagnosed with chronic histiocyte intervillositis, which has characteristics similar to FNAIT.
Review of routine cord platelet testing found very few severe FNAIT cases, with most confirmed cases occurring in European infants.
Certain anti-HPA-1a antibodies can cause platelet aggregation through the FcγRIIa receptor, a mechanism that may contribute to FNAIT.
FNAIT antibodies attack platelets act in different ways, making it hard for doctors to predict how severe the disease may be in each patient.
Platelet unit storage time and mitochondrial DNA levels influenced inflammatory responses that could affect FNAIT complications.